Abstract

Hepatic steatosis develops when lipid influx and production exceed the liver’s ability to utilize/export triglycerides. Obesity promotes steatosis and is characterized by leptin resistance. A role of leptin in hepatic lipid handling is highlighted by the observation that recombinant leptin reverses steatosis of hypoleptinemic patients with lipodystrophy by an unknown mechanism. Since leptin mainly functions via CNS signaling, we here examine in rats whether leptin regulates hepatic lipid flux via the brain in a series of stereotaxic infusion experiments. We demonstrate that brain leptin protects from steatosis by promoting hepatic triglyceride export and decreasing de novo lipogenesis independently of caloric intake. Leptin’s anti-steatotic effects are generated in the dorsal vagal complex, require hepatic vagal innervation, and are preserved in high-fat-diet-fed rats when the blood brain barrier is bypassed. Thus, CNS leptin protects from ectopic lipid accumulation via a brain-vagus-liver axis and may be a therapeutic strategy to ameliorate obesity-related steatosis.

Details

Title
Brain leptin reduces liver lipids by increasing hepatic triglyceride secretion and lowering lipogenesis
Author
Hackl, Martina Theresa 1   VIAFID ORCID Logo  ; Fürnsinn, Clemens 1 ; Schuh, Christina Maria 1   VIAFID ORCID Logo  ; Krssak, Martin 2   VIAFID ORCID Logo  ; Carli, Fabrizia 3 ; Guerra, Sara 4 ; Freudenthaler, Angelika 1 ; Baumgartner-Parzer, Sabina 1 ; Helbich, Thomas H 5   VIAFID ORCID Logo  ; Luger, Anton 1 ; Zeyda, Maximilian 6   VIAFID ORCID Logo  ; Gastaldelli, Amalia 4   VIAFID ORCID Logo  ; Buettner, Christoph 7 ; Scherer, Thomas 1   VIAFID ORCID Logo 

 Department of Endocrinology and Metabolism, Department of Medicine III, Medical University of Vienna, Vienna, Austria 
 Department of Endocrinology and Metabolism, Department of Medicine III, Medical University of Vienna, Vienna, Austria; Department of Biomedical Imaging and Image-Guided Therapy, High-Field MR Center, Medical University of Vienna, Vienna, Austria; Christian Doppler Laboratory for Clinical Molecular MR Imaging, MOLIMA, Vienna, Austria 
 Institute of Clinical Physiology, National Research Council, Pisa, Italy 
 Institute of Clinical Physiology, National Research Council, Pisa, Italy; Institute of Life Sciences, Sant’Anna School of Advanced Studies, Pisa, Italy 
 Department of Biomedical Imaging and Image-Guided Therapy, Division of Molecular and Gender Imaging, Medical University of Vienna, Vienna, Austria 
 Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria 
 Departments of Medicine and Neuroscience, and Diabetes, Obesity and Metabolism Institute (DOMI), Icahn School of Medicine at Mt Sinai, One Gustave L. Levy Pl, New York, NY, USA 
Pages
1-13
Publication year
2019
Publication date
Jun 2019
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2244141444
Copyright
© 2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.